Omeros to present gpr174 data at the european society for medical oncology 2019 immuno-oncology congress in geneva

Seattle--(business wire)--omeros corporation (nasdaq: omer) today announced an upcoming presentation directed to its novel cancer immunotherapy target gpr174 at the european society for medical oncology 2019 immuno-oncology congress, which is being held december 11-14, 2019 in geneva, switzerland. in addition to previously presented ex vivo human and in vivo animal studies, the presentation will include new findings from human t-cells demonstrating that gpr174 inhibition results in downregulati
OMER Ratings Summary
OMER Quant Ranking